SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Volquardsen who wrote (1098)9/9/1998 5:42:00 PM
From: henry jakala  Read Replies (2) of 1115
 
biz.yahoo.com

Wednesday September 9, 4:05 pm Eastern Time

Company Press Release

SOURCE: LIDAK Pharmaceuticals

LIDAK Pharmaceuticals Reports Top
Executives Form 4 Filings with Securities
and Exchange Commission

SAN DIEGO, Sept. 9 /PRNewswire/ -- LIDAK Pharmaceuticals (Nasdaq: LDAKA - news) reported today that board
chairman George P. Rutland, president and CEO Gerald J. Yakatan, Ph.D. and vice president and CFO Gregory P.
Hanson have filed Form 4s with the SEC reporting total purchases of 120,000 shares of LIDAK Class A common
stock made during the past ten days.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext